Cargando…
Asthma caused by durvalumab after chemoradiotherapy in two patients with non‐small cell lung cancer
Durvalumab, an anti‐programmed cell death‐ligand 1 (PD‐L1) antibody, is currently used in the maintenance therapy for patients with stage III non‐small cell lung cancer after platinum‐based chemoradiotherapy. A 69‐year‐old male with lung adenocarcinoma, clinical stage IIIA, was treated with chemorad...
Autores principales: | Uemura, Takehiro, Fukumitsu, Kensuke, Maeno, Ken, Fukuda, Satoshi, Onuki, Tomohiro, Kanemitsu, Yoshihiro, Oguri, Tetsuya, Niimi, Akio, Hida, Toyoaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374598/ https://www.ncbi.nlm.nih.gov/pubmed/34457312 http://dx.doi.org/10.1002/rcr2.835 |
Ejemplares similares
-
Tracheal Glomus Tumor Complicated with Asthma Exacerbation in a Pregnant Woman
por: Fukumitsu, Kensuke, et al.
Publicado: (2022) -
Genetic variation in the ATP binding cassette transporter ABCC10 is associated with neutropenia for docetaxel in Japanese lung cancer patients cohort
por: Sone, Kazuki, et al.
Publicado: (2019) -
Acute Eosinophilic Pneumonia Induced by Switching from Conventional Cigarette Smoking to Heated Tobacco Product Smoking
por: Tajiri, Tomoko, et al.
Publicado: (2020) -
Remarkable Improvement in a Patient with Idiopathic Pulmonary Fibrosis after Treatment with Nintedanib
por: Nakano, Akiko, et al.
Publicado: (2018) -
Characteristics of the European Thoracic Society/American Thoracic Society severe asthma definition as a determinant of future use of biologics/bronchial thermoplasty
por: Nishiyama, Hirono, et al.
Publicado: (2022)